Predictions
MacroGenics Inc.
Start price
Target price
Perf. (%)
€17.00
07.09.21
07.09.21
€15.00
31.12.23
31.12.23
14.50%
09.09.21
09.09.21
Could be very worthwhile Investment >20% year
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€85.80
07.09.21
07.09.21
€110.00
31.12.23
31.12.23
24.13%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Ziopharm Oncology
Start price
Target price
Perf. (%)
€1.99
07.09.21
07.09.21
€4.00
31.12.23
31.12.23
52.84%
01.09.22
01.09.22
Could be worthwhile Investment >10% per year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€5.30
07.09.21
07.09.21
-
07.09.22
07.09.22
-19.25%
18.09.21
18.09.21
Poxel S.A.
Start price
Target price
Perf. (%)
€6.46
06.09.21
06.09.21
€5.00
06.09.22
06.09.22
-9.30%
07.10.21
07.10.21
Could be worthwhile Investment >10% per year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€55.00
06.09.21
06.09.21
€120.00
31.12.23
31.12.23
-43.27%
10.09.21
10.09.21
Could be very worthwhile Investment >20% year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€4.36
06.09.21
06.09.21
-
06.09.22
06.09.22
-32.57%
18.09.21
18.09.21
Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Valneva SE
Start price
Target price
Perf. (%)
€20.78
06.09.21
06.09.21
-
06.09.22
06.09.22
-39.56%
13.09.21
13.09.21
Risky Investment
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€4.36
06.09.21
06.09.21
-
06.09.22
06.09.22
-19.27%
13.09.21
13.09.21
Risky Investment
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€22.47
05.09.21
05.09.21
-
05.09.22
05.09.22
12.86%
19.09.21
19.09.21
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€10.54
05.09.21
05.09.21
-
05.09.22
05.09.22
1.47%
19.09.21
19.09.21
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€4.42
05.09.21
05.09.21
-
05.09.22
05.09.22
-33.48%
19.09.21
19.09.21
Editas Medicine Inc
Start price
Target price
Perf. (%)
€58.60
05.09.21
05.09.21
€70.00
05.09.22
05.09.22
-8.43%
18.09.21
18.09.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Good rating
Very low/no dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€212.55
05.09.21
05.09.21
€333.00
05.09.22
05.09.22
-85.70%
06.09.22
06.09.22
Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model
Quoin Pharmaceuticals Ltd. ADR
Start price
Target price
Perf. (%)
€275.00
05.09.21
05.09.21
-
05.09.22
05.09.22
-98.89%
03.09.22
03.09.22
Risky Investment
Innate Pharma
Start price
Target price
Perf. (%)
€4.80
05.09.21
05.09.21
-
05.09.22
05.09.22
-47.79%
07.03.22
07.03.22
Probably not worthwhile Investment
Innate Pharma
Start price
Target price
Perf. (%)
€4.80
04.09.21
04.09.21
€2.00
04.09.22
04.09.22
37.71%
18.09.21
18.09.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€4.42
04.09.21
04.09.21
€2.00
04.09.22
04.09.22
-33.48%
18.09.21
18.09.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
Innate Pharma
Start price
Target price
Perf. (%)
€6.20
03.09.21
03.09.21
-
03.09.22
03.09.22
-25.29%
06.09.21
06.09.21
Risky Investment
Valneva SE
Start price
Target price
Perf. (%)
€20.18
03.09.21
03.09.21
€30.00
03.09.22
03.09.22
-59.38%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Some uniques
Higher risks for its business